Form 4 · Filed Jun 1, 2026, 08:01 PM UTC
JAZZ/Jazz Pharmaceuticals plc
Mulligan Seamus — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 28, 2026 | M | other | 3,415 | $138 | $471,543 | 1,183,028 |
| May 28, 2026 | M | other | 3,415 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001536639-26-000002